Document is current
Any future updates will be listed below
-
Authors
Eneli, Adaeze
Wang, Kaikai
Gan, Jingyao
Diwan, Rimpy
Lu, Ziyi
Yu, Minzhi
Ackermann, Rose
Shay, Brian
Schwendeman, Anna https://orcid.org/0000-0002-8023-8080
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 20 March 2025
First Online: 2 June 2025
Declarations
:
: Anna Schwendeman declares financial interests for board membership, as a paid consultant, for research funding, and/or as equity holder in EVOQ Therapeutics and ASKO Pharma. The University of Michigan has a financial interest in EVOQ Therapeutics, Inc.
